Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1423-0127

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation ; volume:22 ; number:1 ; day:1 ; month:8 ; year:2015 ; pages:1-11 ; date:12.2015
Journal of biomedical science ; 22, Heft 1 (1.8.2015), 1-11, 12.2015

Creator: Liu, Ya-Wei
Chiu, Yung-Tsung
Fu, Shu-Ling
Huang, Yi-Tsau

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12929-015-0168-5

URN: urn:nbn:de:101:1-2021082106502385223537

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Liu, Ya-Wei
Chiu, Yung-Tsung
Fu, Shu-Ling
Huang, Yi-Tsau
SpringerLink (Online service)

Other Objects (12)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis

MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy

Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells

miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis

MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy

Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells

miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis

MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy

Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells

miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis

MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy

Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells

miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis

MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy

Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells

miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis

MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy

Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells

miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway

Related objects

Reset password